Richard Ethridge, MD
Plastic and Reconstructive Surgery · Fort Worth, TXNPI 1013108299
Payments from drug & device makers
Across 125 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$447
- Sun Pharmaceutical Industries Inc.$443
- Regeneron Healthcare Solutions, Inc.$425
- Lilly USA, LLC$367
- Merz North America, Inc.$183
- AbbVie$168
- plus $757 from 16 others
What the payments were for
- Food & beverage$2,77499%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 17 | $447 |
| Sun Pharmaceutical Industries Inc. | 21 | $443 |
| Regeneron Healthcare Solutions, Inc. | 17 | $425 |
| Lilly USA, LLC | 25 | $367 |
| Merz North America, Inc. | 6 | $183 |
| AbbVie(2 entities) | 7 | $168 |
| Novartis | 5 | $111 |
| Revance Therapeutics, Inc. | 1 | $88 |
| Johnson & Johnson | 4 | $79 |
| Krystal Biotech Inc | 2 | $69 |
| LEO Pharma Inc. | 3 | $61 |
| Convatec Inc. | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| Organon | 2 | $39 |
| Strata Skin Sciences, Inc. | 2 | $35 |
| Organogenesis Inc. | 2 | $31 |
| Blueprint Medicines Corporation | 1 | $28 |
| Almirall LLC | 1 | $26 |
| Mentor Worldwide LLC | 2 | $26 |
| Journey Medical Corporation | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Biofrontera Inc. | 1 | $21 |
How this compares
$2,790 in reported general payments places this provider in the 45th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 15 | $80 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Fort Worth
- Steven MapulaFort Worth$234K
- Robert AndersonFort Worth$75K
- Srikanth KurapatiFort Worth$44K
- Aldona SpiegelHouston$884K
- Patrick GarveyHouston$411K
- Charles ButlerHouston$227K
- Joshua LemmonRichardson$212K
- Michael KlebucHouston$204K
- Jeffrey FriedmanHouston$159K
- Patrick ProfferAmarillo$151K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.